
Philip Morris International, the US tobacco group behind the Marlboro cigarette brand, is to buy specialist pharmaceutical firm Vectura for just over £1bn after outbidding global private equity giant Carlyle. Vectura, which has its roots in a spin-out from the University of Bath, had agreed to Carlyle’s £958m approach but withdrew support after receiving...